Frontier Capital Management CO LLC Ionis Pharmaceuticals Inc Transaction History

Frontier Capital Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$40.53 - $50.7 $2.67 Million - $3.34 Million	-65,838 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$44.08 - $55.05 $1,807 - $2,257	41 Added 0.06%	65,838 $2.9 Million
Q4 2017 Jan 18, 2018	SELL	$50.3 - $64.39 $1.11 Million - $1.43 Million	-22,147 Reduced 25.18%	65,797 $3.31 Million
Q3 2017 Oct 31, 2017	BUY	$45.56 - $59.57 $4.01 Million - $5.24 Million	87,944	87,944 $4.46 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.